In fact, on the basis of our comparative data, we believe that patients with indeterminate thyroid nodules should be initially considered for GAL-3-ICC, a low-cost procedure that proved to be sufficiently highly sensitive and specific. This evidence concerns the gene LGALS3 and thyroid nodule.